| Financial Year |
March 31 2023 |
| Monetary Funds |
205,680,186.59 |
| Held-for-trading Financial Assets |
123,000,000.00 |
| Notes Receivable |
195,282,792.59 |
| Accounts Receivable |
729,719,562.41 |
| Advances to Suppliers |
35,922,620.82 |
| Other Receivables |
19,290,722.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
332,740,516.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,306,662.51 |
| Total Current Assets |
1,712,402,806.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
138,294,196.37 |
| Investment Properties |
9,650,812.49 |
| Fixed Assetes |
347,607,286.76 |
| Under-construction Projects |
221,257,565.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
51,617,713.86 |
| R&D expenses |
15,903,475.15 |
| Goodwill |
85,691,866.89 |
| Long-Term Deferred and Prepaid Expenses |
2,652,744.87 |
| Deferred Income Tax Assets |
22,392,852.43 |
| Other Non-Current Assets |
28,034,466.75 |
| Sub-Total of Non-Current Assets |
934,938,016.34 |
| Total Assets |
2,647,340,822.57 |
| Short-Term Loans |
100,776,350.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,340,000.00 |
| Accounts Payable |
346,897,498.49 |
| Accounts Received In Advance |
5,489,634.14 |
| Employee Compensation Payable |
36,108,118.27 |
| Taxes Payable |
28,576,136.84 |
| Interest Payable |
-- |
| Dividend Payable |
634,547.82 |
| Other payables |
51,587,351.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,356,163.56 |
| Other Current Liabilities |
67,208,889.61 |
| Sub-Total of Current Liabilities |
661,970,937.40 |
| Long-term Loans |
152,416,016.65 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,285,455.95 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,297,512.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
207,646,317.35 |
| Total Liabilities |
869,617,254.75 |
| Paid-In Capital(Or Share Stock) |
592,007,971.00 |
| Capital Surplus |
409,886,577.18 |
| Surplus Reserve |
130,331,771.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
543,718,881.78 |
| Minority Stockholder's Interest |
101,778,365.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,675,945,201.89 |
| Owner's Equity（Stockholder's Equity） |
1,777,723,567.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,647,340,822.57 |
